TrialSpark partners with Limbix for digital therapy clinical trial

By Staff Reporter

- Last updated on GMT

(Image: Getty/Unomat)
(Image: Getty/Unomat)

Related tags: Clinical trial, Digital therapeutic, TrialSpark, Limbix

In the company’s latest partnership, TrialSpark has partnered with Limbix to design and implement a clinical trial for a digital therapeutic for adolescent depression.

Digital health companies are developing in scale, as greater amounts of venture capital funding enters the sector​.

TrialSpark, a technology-focused developer of clinical trials, has utilized this interest to sign another clinical trial partnership agreement with Limbix, which follows shortly on from a similar deal with 23andMe​ and, prior to that, Pfizer.

The latest collaboration will see the two companies partner to plan and instigate a clinical trial for Limbix Spark, which uses mobile and virtual reality (VR) technology to treat adolescent depression.

Limbix Spark itself is a five-week program that uses cognitive behavioral therapy to help teenagers identify behaviors and activities that can influence their mood positively.

TrialSpark will bring the digital therapeutic to doctors through its clinical trial sites, which can recruit patients to fit enrollment criteria for Limbix’s trial of its technology through the use of anonymized, aggregated data of potential patients.

Jeff Yuan, head of client growth at TrialSpark, commented that the company’s network of community physicians allows direct feedback on trials, as well as allowing the digital therapeutic to reach “diverse geographies”​ that would usually not gain access to such treatments.

Related news

Show more

Related products

show more

QPS: Global Custom-Built Research Services

QPS: Global Custom-Built Research Services

QPS | 16-Dec-2019 | Product Brochure

Performing complex studies in special populations with remarkable agility. Clinical research just got better with QPS’ Custom-Built Research Services....

Validating The Simoa Technology

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

Related suppliers

Follow us


View more